Embed this press release by copying the code below:
NASDAQ:XLRN Investor Alert: Investigation over Possible Wrongdoing at Acceleron Pharma Inc.
NASDAQ:XLRN Investor Alert: Investigation over Possible Wrongdoing at Acceleron Pharma Inc.